D C Linehan|P S Goedegebuure|T J Eberlein - JoVE Visualize

Showing results (11-20 of 104) with videos related to

Pageof 11

Sort By:

Zentralblatt Fur Chirurgie|January 1, 1997

[Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"]M Peiper, P S Goedegebuure, T J Eberlein, et al.

Anticancer Research|September 2, 1999

Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neuM Peiper, P S Goedegebuure, J R Izbicki, et al.

Annals of Surgical Oncology|November 1, 1995

Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumorsY L Matory, M Chen, P S Goedegebuure, et al.

Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003

[Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes]M Peiper, P S Goedegebuure, T J Eberlein, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994

Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancerI Yoshino, G E Peoples, P S Goedegebuure, et al.

International Journal of Cancer|February 6, 1999

Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cellsM Nagoshi, N Sadanaga, H G Joo, et al.

Cancer Research|November 26, 1997

Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanomaR A Spanjaard, P J Lee, S Sarkar, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994

Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70I Yoshino, P S Goedegebuure, G E Peoples, et al.

International Journal of Cancer|December 18, 2001

Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytesY Tanaka, K D Amos, H G Joo, et al.

Annals of Surgical Oncology|November 1, 1996

Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitroU L Burger, M P Chang, M Nagoshi, et al.

Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:

Pageof 11

Zentralblatt Fur Chirurgie|January 1, 1997

[Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"]M Peiper, P S Goedegebuure, T J Eberlein, et al.

Anticancer Research|September 2, 1999

Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neuM Peiper, P S Goedegebuure, J R Izbicki, et al.

Annals of Surgical Oncology|November 1, 1995

Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumorsY L Matory, M Chen, P S Goedegebuure, et al.

Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003

[Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes]M Peiper, P S Goedegebuure, T J Eberlein, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994

Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancerI Yoshino, G E Peoples, P S Goedegebuure, et al.

International Journal of Cancer|February 6, 1999

Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cellsM Nagoshi, N Sadanaga, H G Joo, et al.

Cancer Research|November 26, 1997

Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanomaR A Spanjaard, P J Lee, S Sarkar, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994

Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70I Yoshino, P S Goedegebuure, G E Peoples, et al.

International Journal of Cancer|December 18, 2001

Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytesY Tanaka, K D Amos, H G Joo, et al.

Annals of Surgical Oncology|November 1, 1996

Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitroU L Burger, M P Chang, M Nagoshi, et al.

Pageof 11